Ryhan Miah

Commercialisation Junior Officer, Natural Sciences

Ryhan is a Junior Officer for Industry Partnerships & Commercialisation at Imperial’s Faculty of Natural Sciences. He holds an MChem degree in Chemistry w/. Medicinal Chemistry from Newcastle University and a Postgraduate Certificate in Intellectual Property from Bournemouth University.

Ryhan’s portfolio is diverse, covering deep-tech ventures in the quantum field, sustainable chemical technologies, and support for social enterprises and non-profits. Day-to-day he is responsible for assessing the patentability and commercial potential of new inventions, as well as connecting industry partners with academics for collaborative research and/or licensing opportunities.

Ryhan's portfolio

Oligonucleotide Suppression Of Let-7 Binding By H19 To Reduce Sensitivity To Inflammation

Oligonucleotide Suppression Of Let-7 Binding By H19 To Reduce Sensitivity To Inflammation

novel oligonucleotides that bind to H19, displacing Let-7 miRNAs, leading to a reduction in inflammation in muscle tissues, and consequently a reduction in muscle wasting. Find out more

Methods to scale production of hPSC-derived endothelial cells

Methods to scale production of hPSC-derived endothelial cells

A new 3D-culture methodology using stirred-tank bioreactors as a scalable platform for the production of hPSC-derived endothelial cells Find out more

Management of pre-term labour via an application for pathway selective EP2 agonist

Management of pre-term labour via an application for pathway selective EP2 agonist

An EP2 receptor agonist with an application as a novel tocolytic for the management of pre-term labour. Find out more

Sign up for updates

Sign up for monthly technology alerts via email, and find other ways to connect with us.

Loading...